OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Comparative analysis of Bcl-2 family protein overexpression in CAR T cells alone and in combination with BH3 mimetics
Felix Korell, Michael Olson, Diego Salas‐Benito, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 750
Closed Access | Times Cited: 8
Felix Korell, Michael Olson, Diego Salas‐Benito, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 750
Closed Access | Times Cited: 8
Showing 8 citing articles:
CAR-T cell therapy for patients with extramedullary multiple myeloma：opportunities and challenges
Yin Wang, Xiaoli Hu, Juan Du, et al.
European Journal of Cancer (2025) Vol. 220, pp. 115374-115374
Closed Access
Yin Wang, Xiaoli Hu, Juan Du, et al.
European Journal of Cancer (2025) Vol. 220, pp. 115374-115374
Closed Access
BH3 mimetics augment cytotoxic T cell killing of acute myeloid leukemia via mitochondrial apoptotic mechanism
Kapil Saxena, Shao-Hsi Hung, Esther Ryu, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Kapil Saxena, Shao-Hsi Hung, Esther Ryu, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Strategies for Improving CAR T Cell Persistence in Solid Tumors
Megen C Wittling, Anna C Cole, Brianna Brammer, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2858-2858
Open Access | Times Cited: 3
Megen C Wittling, Anna C Cole, Brianna Brammer, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2858-2858
Open Access | Times Cited: 3
Unlocking Apoptotic Pathways: Overcoming Tumor Resistance in CAR ‐T‐Cell Therapy
Zhanna Zhang, Manqi Su, Panruo Jiang, et al.
Cancer Medicine (2024) Vol. 13, Iss. 19
Open Access | Times Cited: 2
Zhanna Zhang, Manqi Su, Panruo Jiang, et al.
Cancer Medicine (2024) Vol. 13, Iss. 19
Open Access | Times Cited: 2
Focusing on CD8+ T-cell phenotypes: improving solid tumor therapy
Zhouchi Yao, Yayun Zeng, Cheng Liu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 1
Zhouchi Yao, Yayun Zeng, Cheng Liu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 1
Optimising CAR T therapy for the treatment of solid tumors
Norhan Mobark, Caroline Hull, John Maher
Expert Review of Anticancer Therapy (2024), pp. 1-17
Open Access
Norhan Mobark, Caroline Hull, John Maher
Expert Review of Anticancer Therapy (2024), pp. 1-17
Open Access
BH3 Mimetics Augment Cytotoxic T Cell Killing of Acute Myeloid Leukemia via Mitochondrial Apoptotic Mechanism
Cassian Yee, Kapil Saxena, Esther Ryu, et al.
Research Square (Research Square) (2024)
Open Access
Cassian Yee, Kapil Saxena, Esther Ryu, et al.
Research Square (Research Square) (2024)
Open Access
Improving the efficacy of cancer immunotherapy by host-defence caerin 1.1 and 1.9 peptides
Quanlan Fu, Yuandong Luo, Junjie Li, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
Quanlan Fu, Yuandong Luo, Junjie Li, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
